Labcorp Holdings Inc. (LH) Operating Margin: 11.03%
Is Labcorp Holdings Inc.’s operating margin high or low?
Labcorp Holdings Inc.'s operating margin of 11.03% is 15% below its 5-year average of 13.00%, near the low end of its 5-year range (5.97%–23.21%).
As of Sunday, June 14, 2026. 14.78% above its 12-month average of 9.61%.
LH Operating Margin Chart
LH Average Operating Margin Chart
LH Current vs Average Operating Margin Chart
LH Operating Margin Metrics
OPERATING MARGIN
11.03%
OPERATING MARGIN AVG TTM
9.61%
OPERATING MARGIN AVG 3Y
9.32%
OPERATING MARGIN AVG 5Y
13.00%
OPERATING MARGIN AVG 10Y
12.68%
OPERATING MARGIN AVG 15Y
14.15%
OPERATING MARGIN AVG 20Y
15.34%
CURRENT VS TTM AVG
+14.78%
CURRENT VS 3Y AVG
+18.28%
CURRENT VS 5Y AVG
-15.15%
CURRENT VS 10Y AVG
-12.99%
CURRENT VS 15Y AVG
-22.04%
CURRENT VS 20Y AVG
-28.09%
LH Competitors' Operating Margin
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $21.83B | 11.03% | 9.61% | 9.32% | 13.00% |
| Mettler-Toledo International Inc. (MTD) | $22.86B | 28.00% | 28.45% | 28.53% | 27.71% |
| BioNTech SE (BNTX) | $22.90B | -51.55% | -35.20% | 5.18% | 14.03% |
| United Therapeutics Corporation (UTHR) | $23.17B | 45.34% | 47.77% | 49.26% | 45.01% |
| Waters Corporation (WAT) | $23.17B | 17.08% | 28.07% | 28.30% | 28.33% |
| Moderna, Inc. (MRNA) | $19.80B | -153.35% | -140.72% | -73.36% | -52.24% |
| Veeva Systems Inc. (VEEV) | $25.92B | 28.79% | 26.93% | 23.33% | 24.40% |
| Hologic, Inc. (HOLX) | $16.97B | 17.49% | 19.66% | 22.41% | 27.16% |
| DexCom, Inc. (DXCM) | $29.08B | 21.45% | 17.22% | 16.09% | 15.13% |
| Biogen Inc. (BIIB) | $29.53B | 15.65% | 22.44% | 23.65% | 25.70% |
Operating Efficiency
Gross Margin
27.8%
Operating Margin
11.0%
Labcorp Holdings Inc. Operating Margin Formula & Definition
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Labcorp Holdings Inc. Operating Margin FAQ
- What is the operating margin for Labcorp Holdings Inc. (LH)?
- The operating margin for LH stock is 11.03%.
- Is Labcorp Holdings Inc.'s operating margin high or low?
- Labcorp Holdings Inc.'s operating margin of 11.03% is 15% below its 5-year average of 13.00%, near the low end of its 5-year range (5.97%–23.21%).
- What is the TTM average operating margin for Labcorp Holdings Inc. (LH)?
- The TTM average operating margin for LH stock is 9.61%.
- What is the 3Y average operating margin for Labcorp Holdings Inc. (LH)?
- The 3Y average operating margin for LH stock is 9.32%.
- What is the 5Y average operating margin for Labcorp Holdings Inc. (LH)?
- The 5Y average operating margin for LH stock is 13.00%.
- What is the 10Y average operating margin for Labcorp Holdings Inc. (LH)?
- The 10Y average operating margin for LH stock is 12.68%.
- What is the 15Y average operating margin for Labcorp Holdings Inc. (LH)?
- The 15Y average operating margin for LH stock is 14.15%.
- What is the 20Y average operating margin for Labcorp Holdings Inc. (LH)?
- The 20Y average operating margin for LH stock is 15.34%.
Labcorp Holdings Inc. Operating Margin History
| DATE | OPERATING MARGIN |
|---|---|
| 2025-12-31 | 10.87% |
| 2024-12-31 | 8.35% |
| 2023-12-31 | 5.97% |
| 2022-12-31 | 12.11% |
| 2021-12-31 | 23.21% |
| 2020-12-31 | 17.49% |
| 2019-12-31 | 11.51% |
| 2018-12-31 | 11.70% |
| 2017-12-31 | 13.07% |
| 2016-12-31 | 13.61% |
| 2015-12-31 | 11.55% |
| 2014-12-31 | 15.14% |
| 2013-12-31 | 17.06% |
| 2012-12-31 | 18.05% |
| 2011-12-31 | 17.11% |
| 2010-12-31 | 19.56% |
| 2009-12-31 | 19.94% |
| 2008-12-31 | 18.71% |
| 2007-12-31 | 19.10% |
| 2006-12-31 | 19.41% |
| 2005-12-31 | 18.57% |
| 2004-12-31 | 19.40% |
| 2003-12-31 | 18.16% |
| 2002-12-31 | 17.35% |
| 2001-12-31 | 16.71% |
| 2000-12-31 | 13.03% |
| 1999-12-31 | 8.81% |
| 1998-12-31 | 7.91% |
| 1997-12-31 | -6.06% |
| 1996-12-31 | -5.96% |
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter